Clinical Trials Directory

Trials / Completed

CompletedNCT02598544

Endocrine Regulation of Lipolysis in Obesity and Diabetes

Atrial Natriuretic Peptide (ANP)-Induced Lipid Mobilization Regulation in Different Adipose Tissue Depots of Obese Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
55 (actual)
Sponsor
Hasselt University · Academic / Other
Sex
Male
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

Adipose tissue (AT) dysfunction is a commonly observed feature of metabolic dysfunction in obesity and diabetes. An important characteristic when examining AT function is the capacity to break down stored lipids (i.e. lipolysis) and its regulation. In the present study, the aim was to investigate whether atrial natriuretic peptide-mediated lipolysis is altered in different adipose tissue depots (subcutaneous and visceral adipose tissue) of obese subjects with or without type 2 diabetes, compared to age-matched lean men. Eventually, the knowledge gained from this research will contribute to a better understanding of the present adipose tissue dysfunction and to the optimization of exercise programs for people with obesity and diabetes.

Conditions

Interventions

TypeNameDescription
OTHERadipose tissue samplingadipose tissue (subcutaneous and visceral adipose tissue) sampling during abdominal surgery and phenotype determination

Timeline

Start date
2013-05-01
Primary completion
2015-04-01
Completion
2015-04-01
First posted
2015-11-06
Last updated
2016-11-18

Locations

4 sites across 2 countries: Belgium, Netherlands

Source: ClinicalTrials.gov record NCT02598544. Inclusion in this directory is not an endorsement.